Cite
APA Citation
Fujiwara, K., Shapira-Frommer, R., Alexandre, J., Monk, B., Fehm, T., Colombo, N., Caceres, M. V., Hasegawa, K., Dubot, C., Li, J. J., Stein, K., Keefe, S. M., & Tewari, K. (n.d.). 265TiPKEYNOTE-826: A phase III randomized study of chemotherapy with or without pembrolizumab for first-line treatment of persistent, recurrent, or metastatic cervical cancer. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100098040231.0x000035